AIDS Community Research Initiative of America (ACRIA) - Summer 2007

In the past decade, since the advent of HIV combination therapy, we have made enormous strides in the treatment of HIV. Drug regimens have been simplified and pill burdens greatly reduced. Effective treatments for drug side effects have brought us closer to the goal of making HIV a "chronic manageable" disease. People with the virus today can expect to live longer and healthier lives than at any time since the epidemic began.

But treatment alone isn't the answer. For one thing, the drugs used to treat HIV are wildly expensive, most notably in developed nations. In the United States, for all our wealth, the cost of providing treatment outstrips government outlays, forcing people onto waiting lists for these lifesaving drugs. Around the world, most people living with HIV go without access to effective treatment, notwithstanding well-publicized international efforts to vastly expand access.

There are other problems with a lifetime of antiretroviral therapy: Even though the situation has much improved, there are still many people who cannot tolerate the side effects of some or all of the available medications. Drug resistance and cross-resistance are a growing concern. And no one knows what unanticipated effects of prolonged use of these powerful drugs may yet turn up.

The fact is that we cannot treat our way out of this epidemic. Prevention is key. This issue of the Update deals with various issues surrounding prevention. On the medical side are articles about the search for a vaccine and effective microbicides, and the use of pre- and post-exposure prophylaxis. First-person stories examine some of the thornier issues of risk behavior, including those who seek sex without condoms.

We must not let the treatment advances of the last ten years make us complacent about HIV. Prevention, ultimately, remains the answer to eradicating this epidemic, and to ending all of the associated costs, especially the devastating human costs.

20070601
CR070601

Copyright © 2007 - AIDS Community Research Initiative of America. Reproduction of this article (other than one copy for personal reference) must be cleared through the Editor, ACRIA Update, 230 West 38th Street, 17th Floor, New York, NY 10018; (212) 924-3934; Fax (212) 924-3936 .

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2007. ÆGIS. All materials appearing on ÆGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of ÆGIS, or the party credited as the provider of the content.